Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL), a global leader in supplemental insurance, provides critical financial protection through innovative products in the U.S. and Japan. This news hub offers investors and stakeholders centralized access to verified corporate developments, strategic initiatives, and market updates.
Track official announcements, product launches, and leadership changes alongside analyses of Aflac's voluntary benefits expansion and technology partnerships. Our curated collection includes earnings reports, regulatory filings, and coverage of community-focused programs like pediatric cancer research support.
Discover updates on Aflac's core insurance offerings including accident, dental, and cancer coverage innovations. Stay informed about operational milestones in both the Japanese and American markets through primary-source documents and contextual reporting.
Bookmark this page for real-time updates on AFL's financial performance, dividend declarations, and industry leadership in supplemental health solutions. Verify all information through direct links to SEC filings and company-issued communications.
Aflac (AFL) is expanding its partnership with Empathy to offer LifeVault™, a digital legacy planning platform, to select group term life insurance certificate holders at no additional cost starting July 1, 2025. LifeVault enables customers to create and manage essential end-of-life documents including wills, advance health care directives, power of attorney, and funeral directives.
This expansion builds upon Empathy's loss support service introduced to Aflac customers in July 2024. The platform streamlines legacy planning, making it more accessible and ensuring members can protect their healthcare, finances, and wishes. The will creation process can typically be completed in under 15 minutes, offering an efficient solution for comprehensive end-of-life planning.
The partnership aims to help families navigate loss and plan for the future, reinforcing Aflac's commitment to supporting customers through challenging life moments.Aflac reported significant changes in its Q1 2025 financial performance. Total revenues decreased to $3.4 billion from $5.4 billion year-over-year, primarily due to net investment losses of $963 million compared to gains of $951 million in Q1 2024. Net earnings dropped to $29 million ($0.05 per share) from $1.9 billion ($3.25 per share).
Key highlights:
- Adjusted earnings reached $906 million, down 5.7% from Q1 2024
- Japan sales increased 12.6% to ¥14.1 billion ($93 million)
- U.S. sales grew 3.5% to $309 million
- Board declared Q2 dividend of $0.58 per share
- Company repurchased 8.5 million shares for $900 million
The company maintained strong capital position with shareholders' equity at $26.3 billion ($48.55 per share). Despite challenges, Aflac showed resilience in both Japanese and U.S. markets, with improved sales and stable premium persistency rates of 93.8% and 79.3% respectively.
Aflac's 2025 Wellness Matters Survey reveals concerning trends in preventive healthcare, with 90% of Americans postponing vital health checkups and screenings. The survey highlights that 94% of Americans face barriers to getting recommended screenings within suggested timeframes.
Key findings show that 48% of Americans face logistical barriers like work conflicts, while 40% have canceled appointments due to long wait times. Generation Z reports high levels of personal embarrassment (32%) and doctor distrust. Common avoided screenings include pap smears (33%), prostate exams (32%), and colonoscopies (32%), with millennials (62%) and Gen Z (61%) being most likely to avoid screenings.
The survey also reveals that 65% of Americans only realize the importance of proactive health care after experiencing a health scare. Notably, nearly 1 in 5 Americans lacks a primary care physician, with 41% primarily using urgent care or emergency rooms for medical needs.
Aflac Incorporated (NYSE: AFL) has scheduled the release of its first quarter 2025 financial results after market close on April 30, 2025. The company will make available its quarterly earnings release and financial supplement on its Investor Relations website, along with a financial update video from CFO Max Brodén.
A conference call webcast is scheduled for May 1, 2025, at 8:00 a.m. ET, where CEO Daniel P. Amos and CFO Brodén will discuss quarterly results. Aflac U.S. President Virgil Miller will join to answer questions alongside other executive management from U.S. and Japan operations. Interested parties can register for the webcast at investors.aflac.com.
TOGETHXR and Aflac have announced the continuation of their partnership with the launch of the 'Raise the Bar' campaign, running from March 17-April 6, 2025. The initiative aims to increase women's sports viewership by encouraging bars nationwide to show the NCAA Women's Basketball Tournament on at least 50% of their TVs.
The partnership includes the creation of an interactive digital map on TOGETHXR.com, helping fans locate bars showing tournament games. This follows their successful 2024 collaborations, which included NCAA-WBB Sweet Sixteen Watch Parties and WNBA All-Star Weekend events.
The companies have also launched 'X Marks the Spot', presented by Aflac, an informational hub showcasing sports bars dedicated to women's sports across the country.
Aflac Incorporated has been recognized as one of the World's Most Ethical Companies for the 19th consecutive year in 2025 by Ethisphere. The company stands as the only insurance provider globally to maintain this recognition since the award's inception in 2007.
Among 136 honorees across 19 countries and 44 industries, Aflac's commitment to ethical practices is demonstrated through various initiatives, including donations of over $187 million to the Aflac Cancer and Blood Disorders Center since 1995 and the distribution of more than 35,000 My Special Aflac Duck® robotic companions to children with cancer and sickle cell disease.
The recognition is based on Ethisphere's Ethics Quotient®, which evaluates companies across multiple criteria including ethics, compliance, governance, and environmental and social impact. Companies recognized on the 2025 list outperformed a comparable index of global companies by 7.8 percentage points from January 2020 to January 2025.
Aflac, the leading U.S. supplemental health insurance provider, has appointed Michael Fradkin as Senior Vice President of Aflac Dental and Vision. Fradkin brings over 30 years of group insurance experience, specializing in dental and vision coverage. He will report to Frederic Simard, Aflac U.S. Executive Vice President, COO and CFO.
In his new role, Fradkin will focus on customer experience, provider network growth, and business expansion. His previous position was president of FastTrack, where he led market expansion and improved service quality. He also held leadership roles at MetLife, Guardian, and Lincoln Financial.
The appointment aligns with Aflac's collaboration with SKYGEN for benefits management and administration. Fradkin, a Rutgers University graduate with expertise in Statistics and Economics, is a fellow of the Society of Actuaries and member of the American Academy of Actuaries.
Aflac, the leading provider of cancer insurance in the US and Japan, has partnered with the American Cancer Society (ACS) to promote early cancer detection and address the physical, emotional, and financial challenges associated with cancer diagnoses.
The collaboration comes as Aflac's 2024 Wellness Matters Survey revealed that 77% of Americans delay important health checkups and 60% avoid cancer screenings. Additionally, the 2024-2025 Aflac WorkForces report found that 70% of employees experience anxiety about serious medical diagnoses and 51% of Americans cannot afford a $1,000 unexpected medical expense.
Through this partnership, Aflac will help promote ACS programs including the Road to Recovery® program offering free rides to medical appointments and Hope Lodge® providing free lodging for cancer patients seeking treatment away from home. ACS will also develop an Employee Toolkit with cancer prevention resources that Aflac associates can share with clients nationwide.
As part of this initiative, Aflac Incorporated President Virgil Miller will establish and chair the first CEOs Against Cancer chapter in Georgia, where both organizations are headquartered.
Aflac (AFL) has launched a new enhanced Accident Insurance product, available in 32 states, offering expanded coverage for post-accident treatments and therapy. The plan nearly doubles coverage for follow-up care and introduces mental health benefits following covered accidents.
Key features include increased preventive care benefits, built-in building benefits for hospital stays that increase annually for up to five years, and enhanced coverage for common accidents like fractures and burns. A special line of duty benefit rider offers an additional $10,000 for first responders injured while working.
According to the 2025 Aflac WorkForces Report, 51% of American employees cannot afford a $1,000 out-of-pocket expense for unexpected medical events, while 22% cannot cover $500. The new policy aims to help bridge this financial gap by providing cash benefits for various medical services including ambulance, ER, urgent care, and therapy services.
Aflac Incorporated (NYSE: AFL) reported strong fourth quarter 2024 results with total revenues of $5.4 billion, up from $3.8 billion in Q4 2023. Net earnings reached $1.9 billion ($3.42 per diluted share), compared to $268 million ($0.46 per diluted share) a year ago.
Adjusted earnings increased 18.2% to $865 million, with adjusted earnings per share up 24.8% to $1.56. The company's full-year 2024 performance showed total revenues up 1.2% to $18.9 billion, with net earnings of $5.4 billion ($9.63 per diluted share).
In Japan, total new annualized premium sales increased 9.0% to ¥17.2 billion, while U.S. sales decreased 4.5% to $534 million. The board declared a first quarter dividend of $0.58 per share, representing a 16% increase. During Q4, Aflac deployed $750 million to repurchase 7.0 million shares.